These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16129059)

  • 1. [Establishment of rhesus model for haploidentical hematopoietic stem cell transplantation with nonmyeloablative conditioning].
    Liu LH; Sun QY; Hu KX; Fan CB; Huang YJ; Bian L; Xiao XB; Yao B; Guo M; Yu CL; Ai HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):677-82. PubMed ID: 16129059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of a rhesus haploidentical hematopoietic stem cell and mesenchymal stem cell transplantation model by nonmyeloablative conditioning].
    Liu LH; Sun QY; Hu KX; Huang YJ; Fan CB; Sun Z; Yao B; Guo M; Zhao CH; Ai HS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):385-8. PubMed ID: 16251015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice].
    Yu JP; Cao S; Xin N; An XM; Qi J; Ren XB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1013-8. PubMed ID: 17956681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
    Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):208-11. PubMed ID: 12812663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
    Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
    Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of nonmyeloablative allogeneic stem cell transplantation model in H-2 haploidentical mice and its related study].
    Li JJ; Zhang Y; Zhang MW; Hou CM; Wu Y; Mao N; Ai HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):655-60. PubMed ID: 15498129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.
    Loren AW; Luger SM; Stadtmauer EA; Tsai DE; Schuster S; Nasta SD; Goldstein SC; Perl A; Orloff G; Oliver JC; Green J; Emerson SG; Porter DL
    Bone Marrow Transplant; 2005 May; 35(9):921-6. PubMed ID: 15765118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model.
    Vanclée A; Lutgens LC; Oving EB; Deutz NE; Gijbels MJ; Schouten HC; Bos GM
    Bone Marrow Transplant; 2005 Nov; 36(10):907-15. PubMed ID: 16151417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of Nonmyeloablative Allogeneic Hematopoietic Stem Cells for 14 Case of Severe Acquired Aplastic Anemia].
    Wang SF; Huang YJ; Yu CL; Sun QY; Qiao JH; Hu KX; Zuo HL; Dong Z; Liu ZQ; Wang Y; Huang XM; Ai HS; Guo M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1097-102. PubMed ID: 26314453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
    Baron F; Sandmaier BM; Storer BE; Maris MB; Langston AA; Lange T; Petersdorf E; Bethge W; Maziarz RT; McSweeney PA; Pulsipher MA; Wade JC; Chauncey TR; Shizuru JA; Sorror ML; Woolfrey AE; Maloney DG; Storb R
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1041-8. PubMed ID: 17697966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
    Tykodi SS; Warren EH; Thompson JA; Riddell SR; Childs RW; Otterud BE; Leppert MF; Storb R; Sandmaier BM
    Clin Cancer Res; 2004 Dec; 10(23):7799-811. PubMed ID: 15585611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer.
    Abe Y; Ito T; Baba E; Nagafuji K; Kawabe K; Choi I; Arita Y; Miyamoto T; Teshima T; Nakano S; Harada M
    Pancreas; 2009 Oct; 38(7):815-9. PubMed ID: 19696692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
    Feinstein L; Sandmaier B; Maloney D; McSweeney PA; Maris M; Flowers C; Radich J; Little MT; Nash RA; Chauncey T; Woolfrey A; Georges G; Kiem HP; Zaucha JM; Blume KG; Shizuru J; Niederwieser D; Storb R
    Ann N Y Acad Sci; 2001 Jun; 938():328-37; discussion 337-9. PubMed ID: 11458521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2 does not enhance the conversion to complete donor chimerism following nonmyeloablative hematopoietic cell transplantation in dogs.
    Georges GE; Storb R; Maciej Zaucha J; Taranova AG; Gooley T; Nash RA
    Bone Marrow Transplant; 2003 Jun; 31(11):1027-31. PubMed ID: 12774055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation.
    Mielcarek M; Kirkorian AY; Hackman RC; Price J; Storer BE; Wood BL; Leboeuf M; Bogunovic M; Storb R; Inamoto Y; Flowers ME; Martin PJ; Collin M; Merad M
    Transplantation; 2014 Sep; 98(5):563-8. PubMed ID: 24717220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
    El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D
    Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.